全文获取类型
收费全文 | 669篇 |
免费 | 27篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 50篇 |
妇产科学 | 13篇 |
基础医学 | 62篇 |
口腔科学 | 32篇 |
临床医学 | 50篇 |
内科学 | 203篇 |
皮肤病学 | 16篇 |
神经病学 | 14篇 |
特种医学 | 154篇 |
外科学 | 25篇 |
综合类 | 12篇 |
预防医学 | 24篇 |
眼科学 | 3篇 |
药学 | 24篇 |
中国医学 | 1篇 |
肿瘤学 | 17篇 |
出版年
2024年 | 1篇 |
2022年 | 1篇 |
2021年 | 11篇 |
2020年 | 4篇 |
2019年 | 5篇 |
2018年 | 11篇 |
2017年 | 3篇 |
2016年 | 3篇 |
2015年 | 11篇 |
2014年 | 23篇 |
2013年 | 19篇 |
2012年 | 10篇 |
2011年 | 22篇 |
2010年 | 33篇 |
2009年 | 35篇 |
2008年 | 35篇 |
2007年 | 22篇 |
2006年 | 15篇 |
2005年 | 15篇 |
2004年 | 13篇 |
2003年 | 15篇 |
2002年 | 4篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 13篇 |
1998年 | 28篇 |
1997年 | 38篇 |
1996年 | 48篇 |
1995年 | 31篇 |
1994年 | 25篇 |
1993年 | 36篇 |
1992年 | 1篇 |
1991年 | 4篇 |
1990年 | 12篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 18篇 |
1986年 | 21篇 |
1985年 | 9篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 18篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 1篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1971年 | 1篇 |
排序方式: 共有702条查询结果,搜索用时 15 毫秒
101.
102.
103.
SNAP-25 deficit and hippocampal connectivity in schizophrenia 总被引:3,自引:2,他引:1
Young CE; Arima K; Xie J; Hu L; Beach TG; Falkai P; Honer WG 《Cerebral cortex (New York, N.Y. : 1991)》1998,8(3):261-268
Regional abnormalities of brain connectivity may be an important substrate
for the expression of schizophrenia, a severe form of mental illness. Brain
imaging and postmortem morphometric studies indicate hippocampal structure
is abnormal in schizophrenia. To study molecular components of hippocampal
connectivity the presynaptic proteins SNAP-25 and synaptophysin were
assayed in postmortem samples. Immunocytochemical studies indicated reduced
SNAP-25 immunoreactivity in schizophrenia compared to controls,
particularly in the terminal fields of entorhinal cortex projections.
Although there were no overall changes in synaptophysin immunoreactivity,
in the granule cell layer of the dentate gyrus synaptophysin
immunoreactivity was increased in schizophrenia. These results indicate
that disconnection of a subset of hippocampal circuitry from the entorhinal
cortex, as well as intrinsic changes in hippocampal connectivity, may
contribute to the mechanism of illness in schizophrenia.
相似文献
104.
MP Busch ; EA Operskalski ; JW Mosley ; CE Stevens ; ER Schiff ; SH Kleinman ; H Lee ; M Lee ; M Harris 《Transfusion》1994,34(10):858-864
BACKGROUND: The long-term course of human immunodeficiency virus type 1 (HIV-1)-related disease among seropositive blood donors has not been described. The enrollment and epidemiologic background of HIV-1- infected donors in the Transfusion Safety Study and their immunologic and clinical progression are described. STUDY DESIGN AND METHODS: Through the testing of approximately 200,000 sera from donations made in late 1984 and early 1985, 146 anti-HIV-1-positive donors and 151 uninfected matched donors were enrolled. These two cohorts were followed with 6-month interval histories and laboratory testing. RESULTS: Seropositive donors detected before the institution of routine anti-HIV-1 screening disproportionately were first-time donors and men with exclusively male sexual contacts. The actuarial probability of a person's developing AIDS within 7 years after donation was 40 percent; the probability of a person's dying of AIDS was 28 percent. AIDS developed more often when the donor was p24 antigen-positive at donation. Over a 3-year period, significant decreases occurred in CD4+, CD2+CD26+, CD4+CD29+, and CD20+CD21+ counts, but not in CD8+ subsets, CD20+, or CD14+. CONCLUSION: The high proportions of first-time donations and exclusively homosexual men among seropositive donors suggest that test-seeking may have contributed to the high HIV-1 prevalence in the repository. Implementation of alternative test sites when routine donor screening began in 1985 may have averted many high- risk donations. The disease course in HIV-1-infected donors had the same wide spectrum of immunologic and clinical manifestations as were reported for other cohorts. 相似文献
105.
J. G. N. de Jong J. M. F. G. Aerts S. van Weely C. E. M. Hollak J. van Pelt L. M. J. van Woerkom M. L. F. Liebrand-van Sambeek R. A. Wevers 《Journal of inherited metabolic disease》1998,21(1):49-59
Gaucher disease is a lysosomal storage disease characterized by storage of glucocerebroside due to lysosomal glucocerebrosidase deficiency. Increased urinary excretion of sialyloligosaccharides and mannosylglycoasparagines has been described for two patients with the infantile form of the disease, probably as a consequence of obstruction of lysosomal functioning due to the glycolipid accumulation in lysosomes. By thin-layer chromatography, we found increased urinary oligosaccharide excretion in a series of adult non-neuronopathic patients. Oligosaccharide patterns were comparable between patients and also with the pattern observed in infantile Gaucher disease. Composition was analysed by methanolysis and gas chromatography. Mannose and N-acetylglucosamine are the main carbohydrates in all oligosaccharide bands. A statistically significant correlation was found between oligosaccharide excretion and the severity of the disease expressed as severity score index. Patients treated with enzyme replacement therapy showed a reduction up to 65% of the original oligosaccharide excretion after 1 year of treatment, comparable with the reduction in spleen volume. 相似文献
106.
107.
de Fost M Vom Dahl S Weverling GJ Brill N Brett S Häussinger D Hollak CE 《Blood cells, molecules & diseases》2006,36(1):53-58
The adult form of Gaucher disease (type I GD) is associated with a high prevalence of hypergammaglobulinemia and monoclonal gammopathy of undetermined significance (MGUS). A significantly increased risk of cancer, especially of hematological types, has been found in Ashkenazi-Jewish GD type 1 patients. In this study, incidence and mortality of cancer were assessed in a total of 131 GD patients of mixed ancestry in a population from Western Europe, i.e. 2 Gaucher referral centers in Germany (Düsseldorf) and the Netherlands (Amsterdam). Standardized rate ratios were determined by indirect standardization, using age- and sex-specific incidence and mortality rates of the Dutch population. A total of 14 GD patients of non-Ashkenazi-Jewish descent were identified of whom 5 had a hematologic malignancy. These numbers correspond to an increased risk of cancer of 2.5 (95% CI 1.1-4.7) and an increased risk of hematologic cancer of 12.7 (95% CI 2.6-37.0) among GD patients compared to the general population. In particular, the incidences of multiple myeloma and hepatocellular carcinoma in absence of preexisting cirrhosis were highly elevated, with standardized rate ratios of 51.1 (95% CI 6.2-184) and 141.3 (95% CI 17.1-510.5), respectively. These strongly increased risks on developing cancer suggest that measures for early detection and prevention of hematological and hepatic malignancies in patients with Gaucher type I disease are mandatory. 相似文献
108.
109.
M. J. van Breemen M. de Fost M. Maas M. G. Wiersma C. E. M. Hollak L. W. Poll S. vom Dahl R. G. Boot J. M. F. G. Aerts 《Journal of inherited metabolic disease》2009,32(2):274-279
Summary In tissue lesions of type I Gaucher patients, characteristic lipid-laden macrophages, ‘Gaucher cells’, are surrounded by inflammatory
phagocytes. Gaucher cells secrete the elevated plasma chitotriosidase. The elevated plasma MIP-1β in Gaucher patients stems
from the phagocytes surrounding the Gaucher cells. Plasma chitotriosidase and MIP-1β decrease upon successful enzyme replacement
therapy (ERT) with mannose-terminated recombinant glucocerebrosidase (alglucerase). Previous histochemical analysis of Gaucher
spleens revealed that Gaucher cells express little mannose receptor, in contrast to surrounding phagocytes. We therefore investigated
the corrective effects of ERT on plasma MIP-1β and chitotriosidase in more detail. We also compared effects of one year of
treatment with a relatively low dose and a relatively high dose of ERT. A more rapid correction in plasma MIP-1β, compared
to chitotriosidase, was observed in most patients on low-dose ERT. Correction of plasma MIP-1β and chitotriosidase levels
was more pronounced in the higher-dosed patient group. Upon prolonged treatment, differences in the effects of enzyme dose
were no longer significant. Normalization of plasma MIP-1β and chitotriosidase levels was attained in the majority of patients.
In conclusion, ERT with mannose-terminated gluocerebrosidase results in prominent corrections of plasma chitotriosidase, a
marker of Gaucher cells, and in particular of plasma MIP-1β, a marker of inflammatory phagocytes. The sharper response in
plasma MIP-1β to ERT is in line with the observation that especially phagocytes surrounding Gaucher cells express mannose-receptors.
Competing interests: None declared
References to electronic databases: Non-neuronopathic Gaucher disease, type I: OMIM 230800. Glucocerebrosidase: EC 3.2.1.45. 相似文献
110.
本研究在于确定胃酸抑制剂是否会增加选择性手术患者术后发生肺炎的风险。
此项人群前瞻性队列研究于1992年4月1日-2008年3月31日在加拿大开展。年龄大于65岁已确定进行选择性手术的患者入组。将本年度在手术前服用过两种或以上胃酸抑制剂的患者以及术前90天内服用过至少一种胃酸抑制剂的患者入试验组, 相似文献